Lactocitrate is a dialysis solution for continuous venovenose haemodialysis (CVVHD) with citrate anticoagulation of 4% trisodium citrate solution and with concomitant administration of calcium, i.e. for continual therapy of renal function. Lactocitrate can only be used in combination with a continuous haemodialysis device, which is also integrated with the citrate and calcium infusion pumps, in addition to the blood flow control pump, the dialysis solution and the filtrate. Lactocitrate is a solution.
Lactocitrate is supplied as a unicameral bag with a total volume of 5000ml. This medical device is intended for professional use only after proper training by the manufacturer.
Composition:
Dialysis solution for immediate use includes:
For complete information, see the Package flyer.
| Sodium lactate | 2.017 g/L |
| Glucose | 1.001 g/L |
| Sodium chloride | 6.550 g/L |
| Potassium chloride | 0.075 G/L |
| Magnesium chloride hexahydrate | 0.305 g/L |
| Potassium dihydrogen phosphate | 0.136 g/L |
Other Ingredients:
Water for injections
The concentration of ions and glucose in the dialysis fluid for immediate use are:
| To+ | 130 mmol/L |
| K+ | 2 mmol/L |
| Mg+ + | 1.5 mmol/L |
| P– | 1 mmol/L |
| Cl– | 116 mmol/L |
| Lactate– | 18 mmol/L |
| Glucose | 5.6 G/L |
| Ph | 6,8 |
| Theoretical osmolarity | 274 Mosmol/L |
